Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 9/2011

01-09-2011 | Original Research

Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis

Authors: Rachel Halpern, Sonalee Agarwal, Leigh Borton, Kathy Oneacre, Maria V. Lopez-Bresnahan

Published in: Advances in Therapy | Issue 9/2011

Login to get access
Metadata
Title
Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis
Authors
Rachel Halpern
Sonalee Agarwal
Leigh Borton
Kathy Oneacre
Maria V. Lopez-Bresnahan
Publication date
01-09-2011
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 9/2011
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-011-0054-9

Other articles of this Issue 9/2011

Advances in Therapy 9/2011 Go to the issue

Review

Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update

Original Research

Long-term efficacy of pitavastatin versus simvastatin

Original Research

Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial

Review

Gouty arthritis: Understanding the disease state and management options in primary care

Original Research

Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting

Review

What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits